RespireRx Pharmaceuticals Inc.
RSPI · OTC
9/30/2023 | 6/30/2023 | 3/31/2023 | 12/31/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$396 | -$681 | -$430 | -$290 |
| Dep. & Amort. | $0 | $0 | $0 | $390,910,663 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | -$2 |
| Change in WC | $178 | $558 | $422 | $116 |
| Other Non-Cash | $117 | -$6 | -$21 | -$390,910,476 |
| Operating Cash Flow | -$101 | -$129 | -$29 | $11 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $66 | $29 | -$11 |
| Stock Issued | $100 | $70 | $0 | -$2 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $70 | $0 | $0 |
| Financing Cash Flow | $100 | $136 | $29 | -$11 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$1 | $7 | $0 | $0 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $7 | $0 | $0 | $0 |
| End Cash | $6 | $7 | $0 | $0 |
| Free Cash Flow | -$101 | -$129 | -$29 | $11 |